As of April 16, 2025, Exscientia (EXAI) has a market cap of $0.63 billion USD. According to our data, Exscientia is ranked No.5674 in global market value.
Year | Market Cap | %Change |
---|---|---|
Nov 20, 2024 | $0.63 B |
-24.49%
|
Dec 29, 2023 | $0.84 B |
20.26%
|
Dec 30, 2022 | $0.70 B |
-73.03%
|
Dec 31, 2021 | $2.59 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Relay Therapeutics
RLAY
|
$0.47 B |
-0.000 M
|
![]() USA
|
![]() Schrödinger
SDGR
|
$1.87 B |
0.235 B
|
![]() USA
|
![]() Recursion Pharmaceuticals
RXRX
|
$2.27 B |
39.023 M
|
![]() USA
|
![]() AbCellera
ABCL
|
$0.72 B |
-0.000 M
|
![]() Canada
|
![]() Absci
ABSI
|
$0.40 B |
-0.000 M
|
![]() USA
|
![]() Atomera
ATOM
|
$0.13 B |
0.000 M
|
![]() USA
|
![]() C4 Therapeutics
CCCC
|
$84.48 M |
0.000 M
|
![]() USA
|
![]() Kymera Therapeutics
KYMR
|
$1.65 B |
0.000 M
|
![]() USA
|
![]() Codexis
CDXS
|
$0.19 B |
0.000 M
|
![]() USA
|
![]() Ginkgo Bioworks
DNA
|
$0.48 B |
0.101 B
|
![]() USA
|
![]() Sana Biotechnology
SANA
|
$0.38 B |
-0.000 M
|
![]() USA
|
![]() Beam Therapeutics
BEAM
|
$1.73 B |
0.000 M
|
![]() USA
|
Market Cap | = | EXAI Stock Price | * | EXAI Shares Outstanding |
= | $4.84 | * | 0.13 B | |
= | $0.63 B |